Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors.
Journal:
Cardiovascular diabetology
PMID:
40176039
Abstract
BACKGROUND: Cardiovascular diseases (CVD) remain the leading cause of morbidity and mortality globally. Traditional risk models, primarily based on established risk factors, often lack the precision needed to accurately predict new-onset major adverse cardiovascular events (MACE). This study aimed to improve prediction and risk stratification by integrating traditional risk factors with biochemical and metabolomic biomarkers.